In addition, a recently published study by our research group showed an increased presence, but not statistically significant, of TGF-β in patients affected by COVID-19 compared to those affected by H1N1pdm09, reinforcing the participation of TGF-β pathways in the development process of pulmonary fibrosis. Here, TGFB1 is linked to COVID-19.